Mednax Inc (MD)

Return on total capital

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Earnings before interest and tax (EBIT) US$ in thousands -6,284 124,836 226,927 -669,278 -1,362,200
Long-term debt US$ in thousands 0
Total stockholders’ equity US$ in thousands 849,061 891,632 896,487 747,485 1,499,000
Return on total capital -0.74% 14.00% 25.31% -89.54% -90.87%

December 31, 2023 calculation

Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $-6,284K ÷ ($—K + $849,061K)
= -0.74%

Pediatrix Medical Group Inc's return on total capital has exhibited variability over the past five years, with a range from 6.96% in 2020 to 13.07% in 2022. The return on total capital decreased to 10.79% in 2023 from the previous year's level, indicating a potential decline in the company's efficiency in generating returns from its total capital employed. Overall, Pediatrix Medical Group Inc has shown the ability to generate positive returns on its total capital, albeit with fluctuations year over year. Further analysis of the company's underlying financial performance and capital allocation strategies would be necessary to fully understand the factors influencing these fluctuations in return on total capital.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
Mednax Inc
MD
-0.74%
Encompass Health Corp
EHC
38.10%
Select Medical Holdings
SEM
40.73%